IP Library Granted Patent US 8,329,231
Granted Patent B2
US 8,329,231 · App. 13/532,380 · Granted Dec 11, 2012

Method of preventing photo-aging with ashwagandha and Indian gooseberry

Assignee: Nutragenesis, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,329,231
App. No.
13/532,380
Granted
Dec 11, 2012
Kind
B2
Abstract

A method of preventing photo-aging and its related causes includes administering a therapeutic composition comprising extracts of the plant species ashwagandha ( Withania somnifera ) and Indian gooseberry ( Phyllanthus emblica ). A composition of ashwagandha and Indian gooseberry may: (1) lower cortisol and increase DHEA, (2) prevent free radical-induced photoaging, (3) inhibit collagenase activity in vitro, (4) inhibit hyaluronidase activity in vitro, (5) display superior cascading antioxidant activity, (6) reduce C-reactive protein, and (7) enhance mood.

Claims (23)

1. A method of reducing photoaging comprising administering to a human a therapeutic composition for internal consumption consisting essentially of a synergistically effective combination of extracts of Phyllanthus emblica and Withania somnifera wherein said Phyllanthus emblica and said Withania somnifera are present in the composition in a weight ratio of about 1:7 Phyllanthus emblica to Withania somnifera to a weight ratio of about 7:1 Phyllanthus emblica to Withania somnifera.

2. The method according to claim 1 , wherein said administering limits free radical creation.

3. The method according to claim 1 , wherein said Phyllanthus emblica and said Withania somnifera are present in the composition in a weight ratio of about 6:2 Phyllanthus emblica to Withania somnifera to a weight ratio of about 2:6 Phyllanthus emblica to Withania somnifera.

4. The method according to claim 1 , wherein the Phyllanthus emblica and Withania somnifera are present in the composition in a weight ratio of about 6:2 Phyllanthus emblica to Withania somnifera to a weight ratio of about 3:5 Phyllanthus emblica to Withania somnifera.

5. The method according to claim 1 , wherein the Phyllanthus emblica and Withania somnifera are present in the composition in a weight ratio of about 6:2 Phyllanthus emblica to Withania somnifera to a weight ratio of about 2:2 Phyllanthus emblica to Withania somnifera.

6. The method according to claim 1 , wherein the Phyllanthus emblica and Withania somnifera are present in the composition in a weight ratio of about 5:3.

7. The method according to claim 1 , wherein the composition comprises about 60 wt. % Withania somnifera to about 65 wt. % Withania somnifera and about 35 wt. % Phyllanthus emblica to about 40 wt. % Phyllanthus emblica.

8. The method according to claim 1 , wherein the administering synergistically inhibits collagenases.

9. The method according to claim 1 , wherein the administering synergistically inhibits hyaluronidase activity.

10. The method according to claim 1 , wherein the synergistic combination is included in a beverage, nutritional product, or food product.

11. A method according to claim 1 , wherein said administration synergistically chelates iron ions.

12. A method of reducing photoaging by limiting free radical creation in a human comprising:

providing an extract of Phyllanthus emblica;

providing an extract of Withania somnifera;

combining the extract of Phyllanthus emblica and the extract of Withania somnifera in a weight ratio of about 1:7 Phyllanthus emblica to Withania somnifera to a weight ratio of about 7:1 Phyllanthus emblica to Withania somnifera so as to create a synergistically effective combination of the extracts; and

adding the combination of extracts to a beverage, nutritional product, or food product for administering the resultant beverage, nutritional product or food product to a human in need thereof.

13. The method according to claim 12 , wherein said Phyllanthus emblica and said Withania somnifera are present in the composition in a weight ratio of about 6:2 Phyllanthus emblica to Withania somnifera to a weight ratio of about 2:6 Phyllanthus emblica to Withania somnifera.

14. The method according to claim 12 , wherein the Phyllanthus emblica and Withania somnifera are present in the composition in a weight ratio of about 6:2 Phyllanthus emblica to Withania somnifera to a weight ratio of about 3:5 Phyllanthus emblica to Withania somnifera.

15. The method according to claim 12 , wherein the Phyllanthus emblica and Withania somnifera are present in the composition in a weight ratio of about 6:2 Phyllanthus emblica to Withania somnifera to a weight ratio of about 2:2 Phyllanthus emblica to Withania somnifera.

16. The method according to claim 12 , wherein the Phyllanthus emblica and Withania somnifera are present in the composition in a weight ratio of about 5:3.

17. The method according to claim 12 , wherein the composition comprises about 60 wt. % Withania somnifera to about 65 wt. % Withania somnifera and about 35 wt. % Phyllanthus emblica to about 40 wt. % Phyllanthus emblica.

18. The method according to claim 12 , wherein the combination synergistically inhibits collagenases when consumed by the human.

19. The method according to claim 12 , wherein the combination synergistically inhibits hyaluronidase activity when consumed by the human.

Assignments (8)
SECURITY INTEREST Recorded Jan 6, 2025
From: INNOPHOS, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 069749/0211 →
CHANGE OF NAME Recorded Mar 13, 2020
From: NOVEL INGREDIENT SERVICES, LLC
To: INNOPHOS, LLC
Reel/Frame 052164/0808 →
MERGER Recorded Feb 20, 2020
From: NUTRAGENESIS, LLC
To: NOVEL INGREDIENT SERVICES, LLC
Reel/Frame 051876/0164 →
PATENT SECURITY AGREEMENT (TL) Recorded Feb 10, 2020
From: INNOPHOS, INC.; INNOPHOS, LLC
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051858/0161 →
PATENT SECURITY AGREEMENT (ABL) Recorded Feb 10, 2020
From: INNOPHOS, INC.; INNOPHOS, LLC
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051858/0131 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2020
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: NUTRAGENESIS, LLC
Reel/Frame 051749/0764 →
SECURITY INTEREST Recorded Jan 17, 2018
From: NUTRAGENESIS, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 044645/0115 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2012
From: MCNEARY, PETER
To: NUTRAGENESIS, LLC
Reel/Frame 028438/0382 →
Continuity (3)
Division 12604092 · Oct 22, 2009
Provisional Application 61107573 · Oct 22, 2008
Related Publication 20120288574A1 · Nov 15, 2012